Advanced Therapies Week

Sterne Kessler’s Bonnie Nannenga-Combs hosted a roundtable session at Advanced Therapies Week, hosted by Phacilitate, on February 11, 2026. Her session, “Maximizing Value of Intellectual Property Portfolios in Cell and Gene Therapies to Attract Investors,” explored strategies for extending loss of exclusivity (LOE) beyond regulatory exclusivity, preparing for investor IP diligence, and understanding the patent landscape to proactively address freedom-to-operate considerations.

Conference Overview

Now in its 21st year, Advanced Therapies Week is the premier biotech partnering event in the United States, bringing together leaders in research, therapeutic development, and advanced manufacturing. The event delivered a high-impact experience that brought together scientific innovation, strategic partnering, and commercialization. From emerging science to scalable solutions, Advanced Therapies Week was a focused forum for the people shaping the future of advanced therapies.